Literature DB >> 11339159

Jaundice and breastfeeding.

L M Gartner1, M Herschel.   

Abstract

Optimal management of breastfeeding does not eliminate neonatal jaundice and elevated serum bilirubin concentrations. Rather, it leads to a pattern of hyperbilirubinemia that is normal and, possibly, beneficial to infants. Excessive frequency of exaggerated jaundice in a hospital or community population of breastfed infants may be a warning that breastfeeding policies and support are not ideal for the establishment of good breastfeeding practices. The challenge to clinicians is to differentiate normal patterns of jaundice and hyperbilirubinemia from those that indicate an abnormality or place an infant at risk.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11339159     DOI: 10.1016/s0031-3955(08)70032-4

Source DB:  PubMed          Journal:  Pediatr Clin North Am        ISSN: 0031-3955            Impact factor:   3.278


  5 in total

Review 1.  Jaundice in the newborn.

Authors:  R Agrawal; R Aggarwal; A K Deorari; V K Paul
Journal:  Indian J Pediatr       Date:  2001-10       Impact factor: 1.967

2.  Antioxidant properties of blirubin in the model organism, Caenorhabditis elegans.

Authors:  Danny McCaughan; Catherine Au; Alexandre Benedetto; Dejan Milatovic; Judy Aschner; Michael Aschner
Journal:  Int J Neuroprot Neuroregener       Date:  2008

3.  Jaundice in the newborns.

Authors:  Satish Mishra; Ramesh Agarwal; Ashok K Deorari; Vinod K Paul
Journal:  Indian J Pediatr       Date:  2008-02       Impact factor: 1.967

4.  Invited commentary: does neonatal hyperbilirubinemia cause asthma?

Authors:  Michael W Kuzniewicz; Andrea C Wickremasinghe; Thomas B Newman
Journal:  Am J Epidemiol       Date:  2013-10-31       Impact factor: 4.897

5.  Neonatal jaundice and stool production in breast- or formula-fed term infants.

Authors:  Hannah D Buiter; Sebastiaan S P Dijkstra; Rob F M Oude Elferink; Peter Bijster; Henk A Woltil; Henkjan J Verkade
Journal:  Eur J Pediatr       Date:  2007-07-10       Impact factor: 3.183

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.